Concord Medical Services Holdings (CCM) Common Equity (2009 - 2025)

Concord Medical Services Holdings has reported Common Equity for 17 years, with the latest figure at -$296.5 million in Q4 2025.

• For the quarter ending Q4 2025, Common Equity rose 6.6% year-over-year to -$296.5 million; the trailing twelve-month figure through Dec 2025 stood at -$296.5 million (up 6.6% YoY), and the FY2025 full-year result was $264.6 million, up 184.68% from the prior year.
• Common Equity for Q4 2025 stood at -$296.5 million, down from $240.4 billion in the prior quarter.
• The five-year high for Common Equity was $369.8 billion in Q2 2022, with the low at -$72.8 billion in Q2 2021.
• Historically, Common Equity has averaged $80.2 billion across 5 years, with a median of $263.0 million in 2023.
• Annual changes were most pronounced in 2021 — Common Equity slumped 258913.12% — and 2024, when it jumped 91697.28%.
• Concord Medical Services Holdings' Common Equity stood at -$146.6 million in 2021, then jumped by 293.37% to $283.4 million in 2022, then declined by 14.39% to $242.6 million in 2023, then tumbled by 230.84% to -$317.5 million in 2024, then grew by 6.6% to -$296.5 million in 2025.
• The last three Common Equity figures came in at -$296.5 million (Q4 2025), $240.4 billion (Q2 2025), and -$317.5 million (Q4 2024), per Business Quant data.